Latest Administration News

Mosaic Brands’ administrators have adjourned the second creditors’ meeting after no restructuring proposal was submitted, prolonging uncertainty over the retail group’s future.

Neurizon Therapeutics reveals that its lead drug candidate NUZ-001 and its metabolite effectively penetrate the blood-brain barrier and reverse pathological protein aggregation linked to ALS, marking a critical step forward in neurodegenerative disease treatment.

EZZ Life Science has launched its US-focused brand EZZDAY with four FDA-registered supplements, marking a major step in its international growth strategy. The company has also begun US-based manufacturing and opened an online store to target American consumers.

Lumos Diagnostics has enrolled 500 patients in its FebriDx CLIA waiver clinical study, unlocking a significant milestone payment from BARDA and moving closer to FDA approval that could open a US$1 billion market.

Makilala Mining has appointed leading consultants to refine and optimise the MCB Copper-Gold Project’s mine plan and infrastructure design, aiming to enhance operational efficiency and environmental outcomes.

Wrkr Ltd has completed a pivotal pilot of its employer services platform with Rest and MUFG Retirement Services, setting the stage for streamlined Payday Super implementation ahead of the July 2026 deadline.

CSL has secured FDA approval for ANDEMBRY®, a pioneering treatment for hereditary angioedema, enabling an immediate US launch with promising clinical results. This milestone marks a significant advance in managing a rare but debilitating condition.

Lotus Resources has begun cold commissioning at its Kayelekera uranium project, targeting a Q3 2025 production restart while adopting an owner-operator mining model to reduce costs and enhance control.

TALi Digital has acquired the You Can Do It! Education program, integrating social-emotional learning into its digital health platform, supported by a $1.5 million equity raise to fund growth and technology reintegration.

Astron Corporation is set to redomicile from Hong Kong to Australia, establishing a new Australian parent company and simplifying shareholder engagement. This move aims to align governance with local standards and boost investor confidence.

Artrya Limited has submitted a pivotal FDA 510(k) application for its AI-powered Salix® Coronary Plaque module, aiming for clearance in Q3 2025 and a lucrative US commercial launch.

Talga Group’s Nunasvaara South graphite mine zoning plan process shifts to regional government after local deadline missed, advancing a key step in Sweden’s battery materials push.